Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 31, 2017
Totally implantable venous access ports: a prospective long-term study of early and late complications in adult patients with cancerEric Voog, Loïc Campion, Pauline du Rusquec, et al.
Journal of the National Cancer Institute|April 20, 2017
Randomized Trial Comparing a Web-Mediated Follow-up With Routine Surveillance in Lung Cancer PatientsFabrice Denis, Claire Lethrosne, Nicolas Pourel, et al.
The Lancet. Oncology|February 15, 2015
Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trialAxel Le Cesne, Jean-Yves Blay, Julien Domont, et al.
The Oncologist|June 24, 2018
Brain Metastases from Adult Sarcoma: Prognostic Factors and Impact of Treatment. A Retrospective Analysis from the French Sarcoma Group (GSF/GETO)Loïc Chaigneau, Anna Patrikidou, Isabelle Ray-Coquard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 29, 2015
Paclitaxel Given Once Per Week With or Without Bevacizumab in Patients With Advanced Angiosarcoma: A Randomized Phase II TrialIsabelle L Ray-Coquard, Julien Domont, Emmanuelle Tresch-Bruneel, et al.
Breast (Edinburgh, Scotland)|September 25, 2013
Circulating tumor cells and response to neoadjuvant paclitaxel and HER2-targeted therapy: a sub-study from the NeoALTTO phase III trialHatem A Azim, Francoise Rothé, Claudia Monica Aura, et al.
BMC Cancer|November 7, 2015
Off-label use of targeted therapies in osteosarcomas: data from the French registry OUTC'S (Observatoire de l'Utilisation des Thérapies Ciblées dans les Sarcomes)Mathilde Penel-Page, Isabelle Ray-Coquard, Julie Larcade, et al.
Neurology|May 12, 2019
Imaging necrosis during treatment is associated with worse survival in EORTC 26101 studyMartha Nowosielski, Thierry Gorlia, Jacoline E C Bromberg, et al.
The New England Journal of Medicine|November 16, 2017
Lomustine and Bevacizumab in Progressive GlioblastomaWolfgang Wick, Thierry Gorlia, Martin Bendszus, et al.
Lancet (London, England)|January 20, 2012
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trialJosé Baselga, Ian Bradbury, Holger Eidtmann, et al.
Pageof 4